US Stock MarketDetailed Quotes
GSK GlaxoSmithKline
- 37.020
- +0.050+0.14%
Close Nov 5 16:00 ET
- 36.380
- -0.640-1.73%
Pre 07:31 ET
75.53BMarket Cap23.39P/E (TTM)
37.050High36.481Low7.09MVolume36.695Open36.970Pre Close260.77MTurnover0.36%Turnover Ratio11.84P/E (Static)2.04BShares45.36052wk High4.13P/B73.12BFloat Cap33.04252wk Low1.60Dividend TTM1.98BShs Float45.360Historical High4.32%Div YieldTTM1.54%Amplitude6.446Historical Low36.790Avg Price1Lot Size
GlaxoSmithKline Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | ||||||||||
| Net income from continuing operations | -95.76%65M | -25.27%1.3B | -33.72%1.08B | 7.86%5.31B | -75.51%398M | 96.92%1.53B | 133.91%1.75B | -7.91%1.63B | 39.96%4.92B | 286.90%1.63B |
| Deferred tax | -100.39%-1M | -21.07%191M | -0.72%274M | 6.93%756M | -2,000.00%-19M | 10.30%257M | 61.33%242M | -14.55%276M | 751.81%707M | 100.85%1M |
| Other non cash items | -21.52%124M | -1.32%150M | -22.99%134M | 34.29%470M | 93.30%-14M | -11.24%158M | -16.94%152M | -12.12%174M | -41.86%350M | -697.14%-209M |
| Change In working capital | -551.22%-740M | 68.99%-618M | 62.98%-311M | -234.81%-364M | 146.00%2.31B | 137.61%164M | -903.63%-1.99B | -75.37%-840M | -80.53%270M | -63.82%937M |
| -Change in receivables | ---- | ---- | ---- | -5.36%-649M | ---- | ---- | ---- | ---- | 46.99%-616M | ---- |
| -Change in inventory | ---- | ---- | ---- | -57.62%-424M | ---- | ---- | ---- | ---- | -627.45%-269M | ---- |
| -Change in other current liabilities | ---- | ---- | ---- | -69.78%492M | ---- | ---- | ---- | ---- | 53.15%1.63B | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -2.62%2.15B | -14.84%1.11B | 1,707.55%958M | -8.58%6.77B | 67.77%3.2B | 67.45%2.21B | -20.06%1.31B | -97.92%53M | -6.90%7.4B | -49.43%1.91B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Net PPE purchase and sale | -5.56%-304M | -2.39%-300M | -9.29%-247M | -28.99%-1.29B | -57.05%-479M | -7.46%-288M | -23.63%-293M | -20.86%-226M | -21.88%-997M | 15.28%-305M |
| Net intangibles purchase and sale | -121.72%-439M | 39.83%-139M | 1.37%-288M | -10.77%-1.02B | -22.22%-297M | -115.22%-198M | -8.96%-231M | 21.51%-292M | 13.55%-919M | -320.91%-243M |
| Net business purchase and sale | 76.71%-17M | 315.68%1.17B | 700.00%312M | 109.28%291M | 16,066.67%958M | 97.56%-73M | -632.43%-542M | 25.71%-52M | -1,795.14%-3.14B | 81.82%-6M |
| Net investment purchase and sale | -102.13%-1M | --0 | --22M | 7,100.00%72M | 2,400.00%25M | --47M | --0 | --0 | -94.44%1M | --1M |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -3,007.38%-3.79B | 89.74%-8M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -48.88%-731M | 179.88%770M | 63.48%-149M | 81.82%-1.6B | 149.63%268M | 88.01%-491M | -76.88%-964M | 88.64%-408M | -393.64%-8.77B | -49.58%-540M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Net issuance payments of debt | 47.51%-548M | -152.03%-539M | -179.17%-323M | 48.72%-2.37B | -582.27%-2.77B | 9.30%-1.04B | 136.79%1.04B | 263.86%408M | -130.75%-4.62B | 71.49%-406M |
| Net common stock issuance | --1M | -66.67%1M | 200.00%18M | -60.00%10M | --1M | --0 | -57.14%3M | -40.00%6M | 19.05%25M | --0 |
| Cash dividends paid | -7.94%-612M | -17.06%-652M | -2.34%-568M | 35.19%-2.25B | 13.15%-568M | 19.57%-567M | 51.82%-557M | 41.70%-555M | 13.30%-3.47B | 31.23%-654M |
| Net other financing activities | 1,337.50%99M | -27.87%44M | -70.77%38M | -96.74%341M | -36.80%158M | -100.94%-8M | 421.05%61M | -98.61%130M | 2,613.94%10.46B | 12,600.00%250M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 29.63%-1.24B | -5,209.68%-1.58B | -233.33%-1.06B | -785.42%-5.64B | -168.46%-3.59B | -32.88%-1.76B | 100.69%31M | -103.99%-318M | 110.84%823M | 51.77%-1.34B |
| Net cash flow | ||||||||||
| Beginning cash position | -5.23%2.88B | -4.89%2.59B | -16.55%2.86B | -10.32%3.43B | -9.90%3.02B | -59.09%3.04B | -74.69%2.72B | -10.27%3.43B | -27.42%3.82B | 4.95%3.35B |
| Current changes in cash | 546.34%183M | -20.05%299M | 62.70%-251M | 14.29%-468M | -574.07%-128M | 99.00%-41M | 111.01%374M | -109.72%-673M | 61.39%-546M | -95.73%27M |
| Effect of exchange rate changes | -247.83%-34M | 85.96%-8M | 38.71%-19M | -165.13%-99M | -173.91%-34M | 0.00%23M | -180.28%-57M | -358.33%-31M | 624.14%152M | 675.00%46M |
| End cash Position | 0.26%3.03B | -5.23%2.88B | -4.89%2.59B | -16.55%2.86B | -16.55%2.86B | -9.90%3.02B | -59.09%3.04B | -74.69%2.72B | -10.32%3.43B | -10.32%3.43B |
| Free cash flow | -23.50%1.31B | -13.08%671M | 182.98%395M | -14.01%4.42B | 109.10%2.41B | 103.92%1.72B | -34.47%772M | -124.14%-476M | -2.89%5.15B | -64.16%1.15B |
| Currency Unit | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
